Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Pain, Postoperative 31Breast Neoplasms 24Agnosia 11Pain 10Lung Neoplasms 10Leiomyoma 7Pancreatic Neoplasms 5Neoplasms 5Prostatic Neoplasms 4Rectal Neoplasms 3Neuroma 3Neuralgia 3Hot Flashes 3Colorectal Neoplasms 3Colonic Neoplasms 3Thyroid Nodule 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphedema 2Liver Neoplasms 2Kidney Neoplasms 2Ileus 2Hyperparathyroidism 2Goiter 2Digestive System Diseases 2Chronic Pain 2Breast Cancer Female 2Brain Neoplasms 2Adenomyosis 2Abdominal Cancer 2

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Standard of Care 1Sodium Chloride 1Self-Help Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Cancer Female × Bupivacaine × Clear all
NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed
60 enrolled
Breast

Breast Cancer Female

NCT03360214 2025-06-15

PEMF and PEC Blocks in Mastectomy Reconstruction Patients

Columbia University

Phase 4 Completed
60 enrolled 11 charts
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡